Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Instituciones de las que forman parte Investigador/a principal Enfermedades Neurovasculares Vall Hebron Institut de Recerca Twitter Maria Mar Hernandez Guillamon Twitter Instituciones de las que forman parte Investigador/a principal Enfermedades Neurovasculares Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Proyectos Sol·licitud de la Dra. Mar Hernández dels contractes Miguel Servet II IP: Joan Montaner Villalonga Colaboradores: Maria Mar Hernandez Guillamon, Laia Perez Lasarte Entidad financiadora: Instituto de Salud Carlos III Financiación: 101250 Referencia: CPII17/00010 Duración: 01/01/2018 - 31/12/2020 Therapeutic effect of rApoA-I-Milano in an AD model IP: Maria Mar Hernandez Guillamon Colaboradores: Anna Penalba Morenilla Entidad financiadora: BrightFocus Foundation Financiación: 254465.28 Referencia: RAPOA-I-MILANO_BRIGTHFOCUSF2017 Duración: 01/07/2017 - 30/06/2021 Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS) IP: - Colaboradores: Anna Rosell Novel, Mercedes Arrue Gonzalo, Bustamante Rangel, Alejandro, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel Entidad financiadora: Instituto de Salud Carlos III Financiación: 240669 Referencia: RD16/0019/0021 Duración: 01/01/2017 - 31/12/2021 Interplay of amyloid and ischemia and their influence on blood-brain barrier, amyloid transportation systems and neurodegeneration in cerebral amyloid angiopathy (CAA) IP: Maria Mar Hernandez Guillamon Colaboradores: - Entidad financiadora: Instituto de Salud Carlos III Financiación: 65340 Referencia: AC15/00030 Duración: 01/01/2016 - 30/11/2020 Paginación Primera página « Página anterior ‹ … Página 2 Página 3 Página actual 4 Página 5 Página 6 … Siguiente página › Última página »
